Company profilePharmaceutical#786 of 1,318 in Pakistan5 DRAP alerts

SAFINA PHARMA (PVT) LTD

Pharmaceutical company · 10 brands · 15 molecules

10 registered products 14 pharmaceutical brands 15 distinct molecules 5 DRAP alerts

Company overview

10
registered products
14
pharmaceutical brands
15
distinct molecules
0
therapeutic classes
5
DRAP alerts

SAFINA PHARMA (PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 10 product registrations across 15 distinct molecules. DRAP has issued 5 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Paracetamol2 brands
Flurbiprofen2 brands
Caffeine1 brand
Lignocaine1 brand
Lignocaine ...................20 Mg1 brand
Lignocain ...... 2 %1 brand
Adrenaline1 brand
Folic Acid1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official2 products · Rs 29.44 – Rs 30.61
DVAGO1 products · Rs 63.98 – Rs 63.98
Median across source: Rs 63.98

Regulatory record

5 alerts in the DRAP feed we track.

129. Recall Alert(Class-I) – DIFAM Injection 3ml (Bosch Pharma) – Substandard
2026-01-14
Recall Alert: Drug Product; Fenbar 50mg Tablets (Batch # 2752) by M/s Usawa Pharmaceutical
2023-01-26
Drug Safety Alert: Risk of Anaphylactic Reaction / Anaphylactic Shock with Diclofenac Sodi
2022-11-18
Recall Alert: Drug Product; Fentos 50mg Tablets (Batch # 599) By M/s. Hisun Pharmaceutical
2022-10-06
Suspension of Drug Registration: Tablets of Diclofenac Potassium in Strengths of 75mg and
2022-06-16

Competitive set

Companies whose registered portfolio overlaps most with this one.

IRZA PHARMA (PVT) LTD.7 shared molecules
MULTINATIONAL BUISNESS LINK7 shared molecules
Albro Pharmaceuticals7 shared molecules
VENUS PHARMA6 shared molecules
EPOCH PHARMACEUTICAL6 shared molecules

Get the full profile for SAFINA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.